The global pharmaceutical intermediates market size is expected to reach around US$ 29 billion by 2030 from US$ 52.6 billion in 2020 and is expected to grow at an impressive double-digit rate of 6.3% from 2021 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global pharmaceutical intermediates market for the period 2017-2030, wherein 2021 to 2030 is the forecast period and 2020 is considered as the base year.
Pharmaceutical chemicals refer to specific type of chemicals that are designed in order to treat the living cells at definite rick when they enter into environment. Pharmaceutical chemicals are basic chemical components used in the production of pharmaceutical drugs. These chemicals have huge demand across the globe as they deliberated as crucial products in the formation of various drugs. Manufacturing processes of these chemicals are designed to maximize their operating flexibility owing to diversity of modern medicinal chemistry. Changing lifestyle and obesity are responsible for the number of diseases including musculoskeletal diseases, infectious diseases, neurology, respiratory diseases, oncology, gastrointestinal diseases, and diabetes among others. Increasing prevalence of these diseases are creating huge demand for the pharmaceutical chemicals. Most of the pharmaceutical chemicals are used in the food production and various end use applications in the pharma sector.
We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1356
Growth Factors:
The global pharmaceutical chemical market is driving due to increasing demand for advanced drugs across the globe. Additionally, constant need of the healthcare facilities, along with increasing old age population worldwide are among major factors to flourish growth of the target industry in the near future. For instance, in Europe the geriatric population aged over 65 found more than 20% in 2019. Growing demand for active pharmaceutical chemicals by the pharmaceutical key players across the globe is expected to augment target industry growth. Furthermore, development of the neurological drugs such as glutamate modulators are supporting to the global industry growth. Changing lifestyle and obesity are leading to increasing various types of chronic diseases which is accelerating the demand for pharmaceutical chemicals.
Moreover, government of developed countries is providing healthcare insurances is having encouraging impact on the growth of global pharmaceutical chemical market. Moreover, increasing government support for innovation especially in the developing countries is another factor to boost growth of the target industry in the near future. Pharmaceutical chemicals are offers various advantages such as less energy consumption as well as cost-effective production which have positive impact on the growth of this industry. Nevertheless, emerging applications of pharmaceutical chemicals is anticipated to create potential opportunities for the growth of the target market.
Regional Analysis:
The report covers data for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America dominated the global market with a market share of more than 35% in 2020. The U.S. registered the highest share in the North American region primarily due to availability of advanced healthcare infrastructure, presence of leading players in the pharmaceutical chemical industry, along with the favorable government policies for the pharmaceutical chemicals production in the region.Further increasing geriatric population and research and development activities by the key companies in the country are other important factors to contribute the high market share of the United States over the forecast period. Further
Europe expected to account for the significant market share in terms of revenue in pharmaceutical chemicals market in the near future. The growth of the pharmaceutical chemicals industry in the countries of the Europe is attributed to growing adoption of the pharmaceutical chemicals in the various end useindustries such as food, cosmetic industries etc. Further, supporting policies for the use of pharmaceutical chemicals by the European government in the region is also projected to increase the demand for pharmaceutical chemicals in the near future. Asia Pacific estimated to grow at the maximum CAGR in the forecast period due increasing demand for chemical pharmaceuticals in the production of active pharmaceutical ingredients such as analgesic drugs, penicillin, vitamins in the countries of the region especially in India, China and Japan of the region.
Report Highlights:
- Among the product segment, basic building blocks segment is dominated the overall market. The advanced intermediates product segment is expected to grow at a significant CAGR during the forecast time-frame. Advanced intermediates encompass the fine and basis chemical.
- Among the application type, cardiovascular segment accounted for the largest revenue with significant share of around 30% in 2020. This is growth is due to increasing prevalence of cardiovascular diseases across the globe. Oncology segment is expected to grow at a significant CAGR during the forecast time-frame.
- BASF segment accounted for a significant share of the global pharmaceutical chemicals market.
Key Market Players and Strategies:
The major companies functioning in the worldwide pharmaceutical chemicals are BASF, Porton Fine Chemicals, Lonza, Johnson Matthey, Dishman, Lanxess, Vertellus Holdings, Jubilant Life Sciences, Hikal, Abbott among others. Noteworthy investment in the research and development of pharmaceutical chemicals coupled with acquisition, mergers, and strategic collaborations are the key business strategies undertaken by the companies operating in the global pharmaceutical chemicals market.
Market Segmentation
By Product
- Basic building blocks
- Advanced intermediates
- Active ingredients
By Application
- Cardiovascular
- Neurology
- Oncology
- Infectious diseases
- Metabolic system
- Diabetes
- Respiratory diseases
- Gastrointestinal diseases
- Musculoskeletal diseases
- Other
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Why should you invest in this report?
If you are aiming to enter the global pharmaceutical intermediates market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for pharmaceutical intermediates are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Key Questions Answered by the Report:
- What will be the size of the global pharmaceutical intermediates market in 2030?
- What is the expected CAGR for the pharmaceutical intermediates market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global pharmaceutical intermediates market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Pharmaceutical Intermediates Market
5.1. COVID-19 Landscape: Pharmaceutical Intermediates Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Pharmaceutical Intermediates Market, By Product
8.1. Pharmaceutical Intermediates Market, by Product Type, 2021-2030
8.1.1. Chemical Intermediates
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Bulk Drug Intermediates
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Custom Intermediates
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Pharmaceutical Intermediates Market, By Application
9.1. Pharmaceutical Intermediates Market, by Application, 2021-2030
9.1.1. Analgesics
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Ant-inflammatory Drug
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Cardiovascular Drugs
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Anti-Cancer Drugs
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Anti-Diabetic Drugs
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Others
9.1.6.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Pharmaceutical Intermediates Market, By End User
10.1. Pharmaceutical Intermediates Market, by End User, 2021-2030
10.1.1. Biotech & Pharma Companies
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Research Laboratory
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. CMO/CRO
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Pharmaceutical Intermediates Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.3. Market Revenue and Forecast, by End User (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.6.3. Market Revenue and Forecast, by End User (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.7.3. Market Revenue and Forecast, by End User (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.3. Market Revenue and Forecast, by End User (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.4.3. Market Revenue and Forecast, by End User (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.5.3. Market Revenue and Forecast, by End User (2019-2030)
Chapter 12. Company Profiles
12.1. Aceto Corporation
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. BASF SE
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Chiracon GmbH
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Yin-sheng Bio-tech Co. Ltd.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Dishman Group
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Green Vision Life Sciences
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Midas Pharma GmbH
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Sanofi SAIS
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Vertellus Holdings LLC.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Lonza Group
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1356
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
0 Comments